High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q3
FY2026Q4
179.92M
-8.01%
0.155
-48.18%
185.81M
-4.63%
0.221
-34.86%
193.19M
+3.43%
0.273
+13.55%
Estimates Revision
The market is revising Downward the revenue expectations for Endava plc (DAVA) for FY2026, with the revenue forecasts being adjusted by -0.03% over the past three months. During the same period, the stock price has changed by -36.35%.
Revenue Estimates for FY2026
Revise Downward
-0.03%
In Past 3 Month
EPS Estimates for FY2026
Revise Downward
-0.74%
In Past 3 Month
Stock Price
Go Down
-36.35%
In Past 3 Month
7 Analyst Rating
Wall Street analysts forecast DAVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DAVA is 10.17 USD with a low forecast of 8.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
5 Hold
0 Sell
Moderate Buy
Current: 6.480
Low
8.00
Averages
10.17
High
15.00
Current: 6.480
Low
8.00
Averages
10.17
High
15.00
Needham
Mayank Tandon
Buy
downgrade
$12 -> $9
2025-11-12
Reason
Needham
Mayank Tandon
Price Target
$12 -> $9
2025-11-12
downgrade
Buy
Reason
Needham analyst Mayank Tandon lowered the firm's price target on Endava to $9 from $12 and keeps a Buy rating on the shares. The company posted Q1 results below expectations on the top and bottom line and lowered FY26 guidance primarily due to an unexpected client credit and subdued pipeline conversion in the quarter, though on a positive note, Endava secured a multi-year relationship with a payments client totaling $100M, the analyst tells investors in a research note. Needham adds however that given its expectations for AI adoption to begin helping growth over 2026 and the potential for increased demand for digital transformation as economic visibility improves, there's potential for the shares to re-rate over time.
JPMorgan
Neutral
downgrade
$13 -> $10
2025-11-12
Reason
JPMorgan
Price Target
$13 -> $10
2025-11-12
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Endava to $10 from $13 and keeps a Neutral rating on the shares. The company reported a fiscal Q1 miss and guidance cut, the analyst tells investors in a research note. The firm sees limited share upside until consensus estimates are "de-risked."
TD Cowen
Bryan Bergin
Hold
downgrade
$10 -> $8
2025-11-12
Reason
TD Cowen
Bryan Bergin
Price Target
$10 -> $8
2025-11-12
downgrade
Hold
Reason
TD Cowen analyst Bryan Bergin lowered the firm's price target on Endava to $8 from $10 and keeps a Hold rating on the shares. The firm noted they missed their previously stated growth guidance with pressure carrying forward into their outlook. A client credit and lack of pipeline conversion drove softer performance.
Guggenheim
Jonathan Lee
Buy
downgrade
$18 -> $15
2025-11-12
Reason
Guggenheim
Jonathan Lee
Price Target
$18 -> $15
2025-11-12
downgrade
Buy
Reason
Guggenheim analyst Jonathan Lee lowered the firm's price target on Endava to $15 from $18 and keeps a Buy rating on the shares. Quarterly underperformance and a negative revision to the company's FY26 outlook overshadow management's incremental confidence in large deals, says the analyst, whose lower target reflects uncertainty in the near term.
William Blair
Maggie Nolan
Outperform -> Market Perform
downgrade
2025-11-11
Reason
William Blair
Maggie Nolan
Price Target
2025-11-11
downgrade
Outperform -> Market Perform
Reason
William Blair analyst Maggie Nolan downgraded Endava to Market Perform from Outperform following "another quarter of disappointing guidance." The firm believes the current setup for a growth recovery is more challenging than previously anticipated and views shares as "likely to remain in the penalty box near term," the analyst tells investors.
Guggenheim
Buy
downgrade
$20 -> $18
2025-09-05
Reason
Guggenheim
Price Target
$20 -> $18
2025-09-05
downgrade
Buy
Reason
Guggenheim lowered the firm's price target on Endava to $18 from $20 and keeps a Buy rating on the shares, though the analyst removed the stock as his "Best Idea" as business momentum will likely take time to materialize. Underperformance in the quarter and a softer-than-expected FY26 outlook "signal the confluence of macroeconomic headwinds," but management's conservatism in its FY26 outlook "appears compelling," the analyst tells investors.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Endava PLC (DAVA.N) is 5.54, compared to its 5-year average forward P/E of 31.29. For a more detailed relative valuation and DCF analysis to assess Endava PLC 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
31.29
Current PE
5.54
Overvalued PE
46.87
Undervalued PE
15.70
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
19.37
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
28.99
Undervalued EV/EBITDA
9.75
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
4.14
Current PS
0.00
Overvalued PS
6.81
Undervalued PS
1.47
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
DAVA News & Events
Events Timeline
(ET)
2025-11-11
07:48:17
Endava and Toyota Racing Development Unveil Extended Multi-Year Partnership
2025-11-11
07:30:49
Endava revises FY26 adjusted EPS forecast down to GBP 0.80-GBP 0.88, previously GBP 0.82-GBP 0.94
2025-11-11
07:28:08
Endava projects Q2 EPS between GBP 0.15 and GBP 0.17
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/default_image/newsfilter.png)
Preview
5.0
11-17NewsfilterEndava Introduces Dava.Rise to Boost Innovation in Enterprises
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/deab3bfa676fb42d0936d797696f2d8114af77f0f6554c32a69144617c4c3d7a.jpg)
Preview
2.0
11-16NASDAQ.COMReasons Behind the Sharp Decline of Endava Stock This Week
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/28849527e9b40e329198d1c41ea2f46b3bf360fe1b7d1b37c6249de4c6441cc9.png)
Preview
9.5
11-14BenzingaAnalysts Cut Paysafe Forecasts After Disappointing Q3 Earnings Report
Sign Up For More News
People Also Watch
FAQ
What is Endava PLC (DAVA) stock price today?
What is Endava PLC (DAVA)'s business?
What is the price predicton of DAVA Stock?
What is Endava PLC (DAVA)'s revenue for the last quarter?
What is Endava PLC (DAVA)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Endava PLC (DAVA)'s fundamentals?
How many employees does Endava PLC (DAVA). have?